This cohort study used data from 31,568 women aged 40–74 without prior breast cancer in the All of Us Research Program...

This report describes results from the phase III lidERA trial evaluating giredestrant, an oral selective estrogen recept...

An artificial intelligence model integrating diverse tumor and patient features was retrospectively compared with a wide...

This review focuses on estrogen receptor–positive early-stage breast cancer in younger premenopausal women (generally...

This publication is a narrative review focused on how to practically implement mainstream germline genetic testing for p...

This study addresses the long‑standing problem that existing breast cancer polygenic risk scores (PRS), largely derive...